T4aN1M0 Subglottic Carcinoma - Clinical Features, Management and Prevention of Pharyngocutaneous Fistula

TNM Staging Interpretation

Part 1: Clinical Features of Subglottic Carcinoma

Symptoms (insidious and late)

Signs

• Biphasic or inspiratory stridor on auscultation
• Fixed or sluggish vocal cord on fibreoptic laryngoscopy (RLN involvement)
• Subglottic fullness or mass on direct laryngoscopy
• Palpable ipsilateral neck lymph node
• Possible thyroid gland fixity or enlargement
• Signs of airway compromise (use of accessory muscles, tracheal tug)

Investigations

1. Fibreoptic nasolaryngoscopy - to assess vocal cord mobility and subglottic extent
2. CT scan neck and chest - to assess cartilage invasion (thyroid/cricoid), extralaryngeal spread, and N1 node characteristics; CT shows soft tissue mass distorting the subglottic airway with sclerosis or destruction of the cricoid cartilage
3. MRI - superior for detecting cartilage marrow invasion (hypointense signal on T1 replacing fat signal)
4. Microlaryngoscopy and biopsy - confirms histology (squamous cell carcinoma in ~95%)
5. PET-CT - for staging and detecting distant disease
6. Thyroid function tests - baseline before treatment
7. Chest X-ray - rule out lung metastasis

Lymph Node Drainage

• Level VI (paratracheal/pretracheal) nodes - most common
• Level III/IV (jugular chain) - the N1 node in this patient is likely here
• Superior mediastinal nodes - along the trachea
• Bilateral drainage is possible, making bilateral neck management important

Part 2: Management of T4aN1M0 Subglottic Carcinoma

Option A: Surgery + Adjuvant Therapy (Standard for T4a)

• Laryngeal framework (thyroid cartilage) is invaded
• Airway reconstruction is difficult when part of the cricoid must be resected
• High risk of submucosal spread requiring a low tracheal resection margin

1. Total laryngectomy with a low tracheal resection to achieve clear inferior margins (due to high risk of submucosal/intraluminal spread inferiorly)
2. Ipsilateral hemithyroidectomy (and isthmus) - because T4a involves extralaryngeal spread; thyroid gland is at risk
3. Bilateral paratracheal node dissection (Level VI) - the primary nodal drainage basin for subglottic SCC
4. Bilateral selective neck dissection (Levels II-IV) - because bilateral nodal spread is common
5. For the N1 node: therapeutic neck dissection on the ipsilateral side; elective selective neck dissection on the contralateral side
6. Permanent tracheostome creation

• Adjuvant radiotherapy (RT) to the neck and superior mediastinum - this is essential for subglottic tumors given the risk of paratracheal and mediastinal nodal spread
• Concurrent chemoradiation (CRT) with cisplatin is indicated if pathology shows: positive margins, extranodal extension, multiple positive nodes, perineural invasion, or lymphovascular invasion
• Dose: 60-66 Gy to the primary bed and involved nodes; 50-54 Gy to elective nodal areas; coverage must include the superior mediastinum

Option B: Organ-Preservation (Concurrent Chemoradiation)

• Only 58% ultimate local control even with surgical salvage for T4 subglottic cancers (Paisley et al.)
• OS for Stage III/IV subglottic SCC is only 38% (5-year) - poor prognosis regardless
• Cartilage destruction makes laryngeal preservation less functionally meaningful
• CRT followed by salvage laryngectomy carries a much higher complication rate (including 30% PCF rate)

Prognosis

• Low tracheal resection with clear margins
• Paratracheal node dissection
• Prophylactic postoperative RT to the stoma and superior mediastinum for high-risk patients (subglottic involvement, paratracheal nodal disease)

Part 3: Prevention of Pharyngocutaneous Fistula (PCF) Post-Surgery

Definition and Significance

Risk Factors for PCF

• Prior radiotherapy or chemoradiation (most significant risk factor - increases fistula rate 3-4 fold)
• Malnutrition / hypoalbuminemia (<3.5 g/dL)
• Diabetes mellitus
• Hypothyroidism (postoperative hypothyroidism increases PCF risk 3.6 times)
• Anaemia
• Alcohol and tobacco use
• Immunosuppression

• T4 tumors with pharyngeal involvement
• Hypopharyngeal extension requiring wider resection
• Subglottic extension (as in this patient)

• Tension on the pharyngeal closure
• Narrow pharyngeal lumen at closure (<3 cm residual pharynx)
• Concurrent neck dissection (increases tissue devascularization)
• Postoperative salivary contamination of the wound
• Wound infection / hematoma

Prevention Strategies

1. Preoperative Optimization

• Nutritional optimization: Aim for albumin >3.5 g/dL; enteral feeding via NG tube or PEG before surgery if nutritional state is poor
• Thyroid function: Check TSH/free T4 preoperatively and ensure euthyroid state
• Anaemia correction: Haemoglobin >10 g/dL before surgery
• Smoking cessation and alcohol abstinence
• Antibiotics: Appropriate perioperative prophylaxis with metronidazole + cephalosporin (covering oral flora including anaerobes)
• Blood glucose control in diabetics

2. Intraoperative Techniques

• Watertight pharyngeal closure: T-shaped closure or horizontal single-layer closure with absorbable sutures (Vicryl); inverting sutures to place mucosa-to-mucosa
• Avoiding tension at the suture line - if there is insufficient pharyngeal mucosa, use a myofascial or mucosal flap
• Salivary bypass tube (Montgomery tube / Blom-Singer): Placed at the time of surgery across the pharyngeal closure to divert saliva away from the suture line; reduces incidence and severity of PCF
• Vascularized tissue interposition - current standard of care, especially in salvage or post-radiation cases:
  • Pectoralis major myofascial (inlay) flap: Placed over the pharyngeal suture line; provides well-vascularized tissue coverage and separates the suture line from the skin
  • Free tissue transfer (anterolateral thigh or radial forearm flap): For patients with significant tissue deficiency or prior pectoralis use
• Nasogastric tube: Maintains decompression of the pharynx in the early postoperative period, keeping pressure off the suture line

3. Postoperative Measures

• Delay of oral feeding: Maintain NPO for 7-10 days (some centres up to 14 days in post-irradiated patients) with NG tube feeding
• Closed suction drains: Prevent seroma/hematoma formation; remove when output <30 mL/24h
• Wound surveillance: Daily inspection of the neck wound for erythema, induration, or salivary leak
• Thyroid replacement: Monitor TSH postoperatively; hypothyroidism significantly increases PCF risk and should be treated promptly
• Nutritional support: Continue enteral nutrition until adequate oral intake is established
• Antibiotics: Continue for 5-7 days post-surgery in high-risk cases

4. Specific Considerations for Post-Radiation/Salvage Cases (relevant if prior CRT was given)

• Vascularized tissue reconstruction is mandatory - even if pharyngeal mucosa appears closable primarily, a pectoralis flap or free flap should be interposed
• Salivary bypass tube + ALT free flap combination has been shown to reduce overall complication rates
• Liberal use of free tissue transfer (Microvascular Committee of AAO-HNS recommendation)

Summary Table: PCF Prevention

Summary for Exam Answer